Browsing by Author O'Connell, Rachel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 36 of 36 < previous 
Issue DateTitleAuthor(s)Citation
2016Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trialBlinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & GynaecologyPatients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185
2016Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trialBlinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & GynaecologyPatients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185
2013Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (field) studyChan, Kim; Donoghoe, Mark; Hoffmann, Linda Sarah; Keech, Anthony (Tony); Ng, Martin; O'Connell, Rachel; Rajamani, Kushwin; Stocker, Roland; Sullivan, David; Yu, Bing; Hamer, A; Vanhala, Mauno J; Whiting, Malcolm; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Bosch Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Medical Sciences: Pathology; Molecular Bioscience; Central Clinical School: MedicinePlasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (field) study, Diabetologia: clinical and experimental diabetes and metabolism, vol.56, 4, 2013,pp 724-736
2011Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatinBeale, Philip; Boyer, Michael; O'Connell, Rachel; Simes, Robert John; Stockler, Martin; Cox, Keith; Goel, Shom; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRandomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin, Internal Medicine Journal, vol.41, 2, 2011,pp 172-178
2004A randomized crossover trial of giving high-dose cisplatin with or without an overnight stay in hospital: Patients' preferences, quality of life, safety and resource useBeale, Philip; Boyer, Michael; O'Connell, Rachel; Simes, Robert John; Stockler, Martin; Cox, K; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA randomized crossover trial of giving high-dose cisplatin with or without an overnight stay in hospital: Patients' preferences, quality of life, safety and resource use, Journal of Clinical Oncology (Print), vol.22,(14S),2004,pp 547S-547S
2017Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer RecurrenceAsher, Rebecca; Beith, Jane; Bell, Melanie Lynn; Butow, Phyllis; Fardell, Joanna; Gebski, Val; Grunewald Zola, Karina; O'Connell, Rachel; Sharpe, Louise; Smith, Allan; Tesson, Stephanie; Thewes, Belinda; Gilchrist, Jemma; Girgis, Afaf; Mihalopoulos, Cathrine; Turner, Jane; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Psychology; Psychology; Psychology; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; Psychology; Psychology; Psychology; PsychologyRandomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence, Journal of Clinical Oncology, vol.35, 36, 2017,pp 4066-4077
2013Rates and predictors of risk of stroke and its subtypes in diabetes: A prospective observational studyKeech, Anthony (Tony); O'Connell, Rachel; Ting, Ru Dee; Veillard, Anne-Sophie; Anderson, Neil; Hankey, Graeme; Hunt, David; Romo, Matti; Sullivan, David Richmond; Wosik, Melinda; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRates and predictors of risk of stroke and its subtypes in diabetes: A prospective observational study, Journal of Neurology, Neurosurgery and Psychiatry, vol.84, 3, 2013,pp 281-287
2017Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyBuizen, L; King, Madeleine; O'Connell, Rachel; Roncolato, Felicia; Stockler, Martin; Aotani, Enriko; Avall-Lundqvist, Elisabeth; Berek, Jonathan; Berton-Rigaud, Dominique; Donnellan, Paul; Feeney, Amanda; Friedlander, M; Heitz, Florian; Hilpert, Felix; Joly, F; Lanceley, Anne; Okamoto, Aikou; Oza, Amit; Pignata, Sandro; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreReducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study, The Oncologist, vol.22, 9, 2017,pp 1117-1124
2015Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes studyBarter, Philip; Buizen, L; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Sullivan, David; Scott, Russell; Taskinen, M; Xu, Aimin; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials CentreRelationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study, Diabetologia, vol.59, 8, 2015,pp 2035-2044
2015The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyBarter, Philip; Hung, Wei Ting; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Sullivan, David; Scott, Russell; Taskinen, M.; Xu, Aimin; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Other or Unknown; NH&MRC Clinical Trials CentreThe relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study, Diabetologia, vol.58, 3, 2015,pp 464-473
2005A simple prognostic score for the re-infarction risk following fibrinolytic therapy for myocardial infarction - data from HERO-2O'Connell, Rachel; Simes, Robert John; Aylward, Philip A.; Edmond, John J.; French, J K; White, H D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA simple prognostic score for the re-infarction risk following fibrinolytic therapy for myocardial infarction - data from HERO-2, European Heart Journal (English Edition), vol.26, Suppl 1,pp 561-561
2012Stratified additive Poisson models: Computational methods and applications in clinical epidemiologyMarschner, Ian (Colin); O'Connell, Rachel; Gillet, Alexandra; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreStratified additive Poisson models: Computational methods and applications in clinical epidemiology, Computational Statistics and Data Analysis, vol.56, 5, 2012,pp 1115-1130
2014Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit studyButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Donovan, Heidi; Oza, Amit; Symptom Benefit Study Group, .; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSymptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study, International Journal of Gynecological Cancer, vol.24, 5, 2014,pp 857-864
2017TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTGGebski, Val; Miller, Danielle; O'Connell, Rachel; Simes, Robert John; Verghis, Jaclyn; Boussioutas, A; et al, Various; Findlay, M; Haustermans, Karin; Kron, Thomas; Leong, T; Michael, Michael; Smithers, B. Mark; Willis, David; Zalcberg, John; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreTOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG, Annals of Surgical Oncology, vol.24, 8, 2017,pp 2252-2258
2010Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.Marschner, Ian; O'Connell, Rachel; Simes, Robert John; Armstrong, Paul W.; Aylward, Philip E G; Califf, Robert M.; Diaz, Raphael; French, John K; Granger, Christopher B.; Van de Werf, Frans; Varshavsky, Sergei; White, Harvey D.; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreUnexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial., American Heart Journal, vol.159, 6,pp 988-997
2007Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2O'Connell, Rachel; Simes, Robert John; Aylward, Philip E.G.; de Pasquale, Carmen G.; Edmond, John J.; et, al; French, J. K.; Stewart, Ralph A.H.; Van de Werf, Frans J.; van den Berg, K.; Williams, Barbara F.; Wong, C. K.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreVariations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2, European Heart Journal, vol.28,(12),2007,pp 1418-1424